ERBB2 c.478_480delinsAAC ;(p.Q160N)

Variant ID: 17-37865609-CAG-AAC

NM_004448.2(ERBB2):c.478_480delinsAAC;(p.Q160N)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity.

Pharmaceutics
Cruz, Esteban E; Sifniotis, Vicki V; Sumer-Bayraktar, Zeynep Z; Reslan, Mouhamad M; Wilkinson-White, Lorna L; Cordwell, Stuart S; Kayser, Veysel V
Publication Date: 2021-10-20

Variant appearance in text: HER2: Q160N
PubMed Link: 34834161
Variant Present in the following documents:
  • Main text
  • pharmaceutics-13-01747.pdf
View BVdb publication page